Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Szalowska, Ewa ^a   Tesfay, Haftu A ^a   van Hijum, Sacha A ^b   Kersten, Sander ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fibrates; Inflammation; Lipid metabolism; Mouse liver models; Parenchymal and non parenchymal liver cells; Peroxisome proliferator activated receptor alpha (PPAR ); Transcriptomics

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSCRIPTOME; PIRINIXIC ACID; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIPID METABOLISM; LIVER CELL; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DBA MOUSE; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM;

RODENTIA;

ANIMALS; CELLS, CULTURED; FEMALE; HEPATOCYTES; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PPAR ALPHA; PYRIMIDINES; TRANSCRIPTOME;

EID: 84925647500     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-1106     Document Type: Article

References (54)

1. Reddy JK, Moody DE, Azarnoff DL, Tomarelli RM: Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse. Arch Int Pharmacodyn Ther 1977,225(1):51-57.
2. Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990,347(6294):645-650. 10.1038/347645a0.
3. Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and disease. Nature 2000,405(6785):421-424. 10.1038/35013000.
4. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 1994,91(15):7355-7359. 10.1073/pnas.91.15.7355.
5. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999,103(11):1489-1498. 10.1172/JCI6223.
6. Leone TC, Weinheimer CJ, Kelly DP: A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 1999,96(13):7473-7478. 10.1073/pnas.96.13.7473.
7. Linden D, Lindberg K, Oscarsson J, Claesson C, Asp L, Li L, Gustafsson M, Boren J, Olofsson SO: Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. J Biol Chem 2002,277(25):23044-23053. 10.1074/jbc.M110416200.
8. Ameen C, Edvardsson U, Ljungberg A, Asp L, Akerblad P, Tuneld A, Olofsson SO, Linden D, Oscarsson J: Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver. J Biol Chem 2005,280(2):1224-1229. 10.1074/jbc.M412107200.
9. Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T: Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 1998,273(45):29577-29585. 10.1074/jbc.273.45.29577.
10. Linden D, Alsterholm M, Wennbo H, Oscarsson J: PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins. J Lipid Res 2001,42(11):1831-1840.
11. Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B: Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence. Arterioscler Thromb Vasc Biol 2006,26(5):977-986. 10.1161/01.ATV.0000204327.96431.9a.
12. Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, Baron M, Lucas A, Tailleux A, Hum DW, Ratziu V, Cariou B, Hanf R: Hepato-protective effects of the dual PPARalpha/delta agonist GFT505 in rodent models of NAFLD/NASH. Hepatology 2013,58(6):1941-1952. 10.1002/hep.26461.
13. Wahli W, Michalik L: PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 2012,23(7):351-363. 10.1016/j.tem.2012.05.001.
14. Delerive P, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 2001,169(3):453-459. 10.1677/joe.0.1690453.
15. Gervois P, Vu-Dac N, Kleemann R, Kockx M, Dubois G, Laine B, Kosykh V, Fruchart JC, Kooistra T, Staels B: Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem 2001,276(36):33471-33477. 10.1074/jbc.M102839200.
16. Hoekstra M, Kruijt JK, Van Eck M, Van Berkel TJ: Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J Biol Chem 2003,278(28):25448-25453. 10.1074/jbc.M301189200.
17. Peters JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman RG: Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 2000,21(4):823-826. 10.1093/carcin/21.4.823.
18. Daynes RA, Jones DC: Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2002,2(10):748-759. 10.1038/nri912.
19. Eheim A, Medrikova D, Herzig S: Immune cells and metabolic dysfunction. Semin Immunopathol 2014,36(1):13-25. 10.1007/s00281-013-0403-7.
20. Jones DC, Ding X, Daynes RA: Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 2002,277(9):6838-6845. 10.1074/jbc.M106908200.
21. Reichenbach G, Starzinski-Powitz A, Sloane BF, Doll M, Kippenberger S, Bernd A, Kaufmann R, Meissner M: PPARalpha agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms. Angiogenesis 2013,16(1):223-233. 10.1007/s10456-012-9314-9.
22. Rizvi YQ, Mehta CS, Oyekan A: Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis. Vasc Pharmacol 2013,59(5-6):144-151.
23. Hu Y, Chen Y, Ding L, He X, Takahashi Y, Gao Y, Shen W, Cheng R, Chen Q, Qi X, Boulton ME, Ma JX: Pathogenic role of diabetes-induced PPAR-alpha down-regulation in microvascular dysfunction. Proc Natl Acad Sci U S A 2013,110(38):15401-15406. 10.1073/pnas.1307211110.
24. Li Z, Kruijt JK, van der Sluis RJ, Van Berkel TJ, Hoekstra M: Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells. Physiol Genomics 2013,45(7):268-275. 10.1152/physiolgenomics.00151.2012.
25. Rakhshandehroo M, Hooiveld G, Muller M, Kersten S: Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One 2009,4(8):e6796. 10.1371/journal.pone.0006796.
26. Szalowska E, van der Burg B, Man HY, Hendriksen PJ, Peijnenburg AA: Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices. PLoS One 2014,9(1):e86795. 10.1371/journal.pone.0086795.
27. Rakhshandehroo M, Sanderson LM, Matilainen M, Stienstra R, Carlberg C, de Groot PJ, Muller M, Kersten S: Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR Res 2007, 2007:26839.
28. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004,5(10):R80. 10.1186/gb-2004-5-10-r80.
29. Qu Y, He F, Chen Y: Different effects of the probe summarization algorithms PLIER and RMA on high-level analysis of Affymetrix exon arrays. BMC Bioinformatics 2010, 11:211. 10.1186/1471-2105-11-211.
30. Breitling R, Armengaud P, Amtmann A, Herzyk P: Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 2004,573(1-3):83-92.
31. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003,4(5):3. 10.1186/gb-2003-4-5-p3.
32. da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1):44-57.
33. Oliveros JC: VENNY. An interactive tool for comparing lists with Venn Diagrams. [ http://bioinfogp.cnb.csic.es/tools/venny/ ]
34. da Huang W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009,37(1):1-13. 10.1093/nar/gkn923.
35. Glass CK, Olefsky JM: Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 2012,15(5):635-645. 10.1016/j.cmet.2012.04.001.
36. Hong F, Breitling R: A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments. Bioinformatics 2008,24(3):374-382. 10.1093/bioinformatics/btm620.
37. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J: RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 2006,22(22):2825-2827. 10.1093/bioinformatics/btl476.
38. Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Bottger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, et al.: Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013,87(8):1315-1530. 10.1007/s00204-013-1078-5.
39. Tamura K, Ono A, Miyagishima T, Nagao T, Urushidani T: Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. J Toxicol Sci 2006,31(5):471-490. 10.2131/jts.31.471.
40. de Graaf IA, Olinga P, de Jager MH, Merema MT, de Kanter R, van de Kerkhof EG, Groothuis GM: Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc 2010,5(9):1540-1551. 10.1038/nprot.2010.111.
41. Hasmall S, James N, Hedley K, Olsen K, Roberts R: Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha). Arch Toxicol 2001,75(6):357-361. 10.1007/s002040100246.
42. Fang X, Zou S, Zhao Y, Cui R, Zhang W, Hu J, Dai J: Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor alpha expression by releasing cytokines. Arch Toxicol 2012,86(10):1515-1525. 10.1007/s00204-012-0877-4.
43. Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van Rooijen N, Staels B, Kersten S, Muller M: Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 2010,51(2):511-522. 10.1002/hep.23337.
44. Elvevold K, Smedsrod B, Martinez I: The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am J Physiol Gastrointest Liver Physiol 2008,294(2):G391-G400.
45. Sandoval A, Fraisl P, Arias-Barrau E, Dirusso CC, Singer D, Sealls W, Black PN: Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking. Arch Biochem Biophys 2008,477(2):363-371. 10.1016/j.abb.2008.06.010.
46. Guo L, Li SY, Ji FY, Zhao YF, Zhong Y, Lv XJ, Wu XL, Qian GS: Role of Angptl4 in vascular permeability and inflammation. Inflamm Res 2014,63(1):13-22. 10.1007/s00011-013-0678-0.
47. Mehrotra D, Wu J, Papangeli I, Chun HJ: Endothelium as a gatekeeper of fatty acid transport. Trends Endocrinol Metab 2014,25(2):99-106. 10.1016/j.tem.2013.11.001.
48. Record M, Carayon K, Poirot M, Silvente-Poirot S: Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta 2014,1841(1):108-120. 10.1016/j.bbalip.2013.10.004.
49. Iglesias J, Barg S, Vallois D, Lahiri S, Roger C, Yessoufou A, Pradevand S, McDonald A, Bonal C, Reimann F, Gribble F, Debril MB, Metzger D, Chambon P, Herrera P, Rutter GA, Prentki M, Thorens B, Wahli W: PPARbeta/delta affects pancreatic beta cell mass and insulin secretion in mice. J Clin Invest 2012,122(11):4105-4117. 10.1172/JCI42127.
50. Banni S, Carta G, Murru E, Cordeddu L, Giordano E, Marrosu F, Puligheddu M, Floris G, Asuni GP, Cappai AL, Deriu S, Follesa P: Vagus nerve stimulation reduces body weight and fat mass in rats. PLoS One 2012,7(9):e44813. 10.1371/journal.pone.0044813.
51. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen RH, Howard MJ, Arends JJ, Desantis P, Coleman T, Semenkovich CF: An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab 2007,5(2):91-102. 10.1016/j.cmet.2006.12.010.
52. Reddy JK, Rao MS, Azarnoff DL, Sell S: Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver. Cancer Res 1979,39(1):152-161.
53. Karam WG, Ghanayem BI: Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures. Carcinogenesis 1997,18(11):2077-2083. 10.1093/carcin/18.11.2077.
54. Guo L, Fang H, Collins J, Fan XH, Dial S, Wong A, Mehta K, Blann E, Shi L, Tong W, Dragan YP: Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists. BMC Bioinformatics 2006,7(Suppl 2):S18. 10.1186/1471-2105-7-S2-S18.